HCA Healthcare Revenue by Segment

Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024
American Group	26.77B	26.68B	26.45B	26.20B	25.53B	25.02B	24.60B	24.00B
American Group Growth	4.84%	6.64%	7.50%	9.16%	8.77%	8.62%	10.23%	11.35%
Atlantic Group	26.36B	24.91B	24.71B	24.63B	24.06B	23.66B	23.17B	22.52B
Atlantic Group Growth	9.52%	5.26%	6.64%	9.34%	7.35%	8.86%	9.47%	9.32%
National Group	21.59B	21.53B	21.28B	20.90B	20.27B	19.88B	19.61B	19.27B
National Group Growth	6.50%	8.30%	8.48%	8.48%	8.21%	8.75%	8.33%	8.71%
Corporate and Other	3.30B	3.27B	3.17B	2.64B	2.83B	3.02B	3.22B	3.83B
Corporate and Other Growth	16.55%	8.17%	-1.52%	-30.97%	-23.96%	-17.52%	-4.77%	16.75%

Adjusted EBITDA by Segment

Period Ending	Jun 30, 2026	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024
Atlantic Group	6.09B	5.62B	5.64B	5.37B	5.18B	5.15B	4.97B	5.03B
Atlantic Group Growth	17.58%	9.21%	13.48%	6.72%	2.96%	9.58%	10.69%	17.88%
American Group	6.08B	6.29B	6.30B	6.19B	5.99B	5.83B	5.74B	5.66B
American Group Growth	1.52%	7.85%	9.76%	9.36%	9.02%	8.14%	10.14%	10.37%
National Group	5.14B	5.23B	5.10B	4.92B	4.66B	4.49B	4.43B	4.43B
National Group Growth	10.44%	16.48%	15.32%	10.92%	12.33%	14.54%	10.63%	15.44%
Corporate and Other	-800.00M	-1.51B	-1.48B	-1.32B	-1.27B	-1.21B	-1.25B	-1.34B